A large number of peptides currently being marketed to the public are not FDA approved. These include BPC 157, LL 37, DSIP, Epitalon, GHK Cu (injectable), GHRP 2, GHRP 6, ipamorelin, kisspeptin 10, KPV, melanotan II, PEG MGF, MOTS C, GHK Cu, BPC 157, TB 500, KPV Injectable Peptide Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. GHK Cu FDA Approval Status 2026: Not Approved